Immunovaccine Announces Positive Phase 1 Topline Data for DepoVax(TM)-based Respiratory Syncytial Virus Vaccine Candidate
HALIFAX, NOVA SCOTIA–(Marketwired – Oct. 13, 2016) – Immunovaccine Inc. (“Immunovaccine” or the “Company”) (TSX:IMV)(OTCQX:IMMVF), a clinical stage [...]